Q3 2024 Earnings Estimate for Sarepta Therapeutics, Inc. Issued By Zacks Research (NASDAQ:SRPT)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Equities research analysts at Zacks Research boosted their Q3 2024 earnings per share estimates for shares of Sarepta Therapeutics in a research note issued on Thursday, January 11th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will earn $0.29 per share for the quarter, […]
More Stories
Ripe for the Picking Season 2: Release Date, Cast, and More
Ripe for the Picking is a Japanese manga series. It was first released as a magazine before becoming a web...
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...
Let’s Talk About Chu Season 2: Release Date, Cast, and More
The romantic-comedy Taiwanese series Let’s Talk About Chu has become one of the most talked-about series since its release in...
Office Romance is Released! Watch Jennifer Lopez and Brett Goldstein’s Exotic Romance
Looking for a romantic-comedy film to watch with your partner or loved ones this weekend? Jennifer Lopez’s recent film, Office...
The Quiet Logistics Shift Changing How Shoppers Collect Fresh Food
Nobody talks about this, but it’s happening everywhere. The way grocery stores handle order collection is changing. Not in a...
Why Offices Sound Worse Than Ever, And the Engineering Fix Hiding in Plain Sight
Open-plan offices were meant to feel modern, bright, and collaborative. In reality, many feel like a mix of café, hallway,...